About: Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques
Creator	Sayan, Murat Sanlidag, Tamer Ozsahin, Ilker Uzun, Berna Dilber, Uzun Ozsahin, Yildirim, Figen
Source	Medline; PMC
abstract	In December 2019, cases of pneumonia were detected in Wuhan, China, which were caused by the highly contagious coronavirus. This study is aimed at comparing the confusion regarding the selection of effective diagnostic methods to make a mutual comparison among existing SARS-CoV-2 diagnostic tests and at determining the most effective one. Based on available published evidence and clinical practice, diagnostic tests of coronavirus disease (COVID-19) were evaluated by multi-criteria decision-making (MCDM) methods, namely, fuzzy preference ranking organization method for enrichment evaluation (fuzzy PROMETHEE) and fuzzy technique for order of preference by similarity to ideal solution (fuzzy TOPSIS). Computerized tomography of chest (chest CT), the detection of viral nucleic acid by polymerase chain reaction, cell culture, CoV-19 antigen detection, CoV-19 antibody IgM, CoV-19 antibody IgG, and chest X-ray were evaluated by linguistic fuzzy scale to compare among the diagnostic tests. This scale consists of selected parameters that possessed different weights which were determined by the experts' opinions of the field. The results of our study with both proposed MCDM methods indicated that the most effective diagnosis method of COVID-19 was chest CT. It is interesting to note that the methods that are consistently used in the diagnosis of viral diseases were ranked in second place for the diagnosis of COVID-19. However, each country should use appropriate diagnostic solutions according to its own resources. Our findings also show which diagnostic systems can be used in combination.
has issue date	2020-08-06(xsd:dateTime)
bibo:doi	10.1155/2020/1560250
bibo:pmid	32802146
has license	cc-by
sha1sum (hex)	afadee586ba2b16d0ec3ae8b2c5df96178ec328f
schema:url	https://doi.org/10.1155/2020/1560250
resource representing a document's title	Capacity Evaluation of Diagnostic Tests For COVID-19 Using Multicriteria Decision-Making Techniques
has PubMed Central identifier	PMC7411452
has PubMed identifier	32802146
schema:publication	Comput Math Methods Med
resource representing a document's body	covid:afadee586ba2b16d0ec3ae8b2c5df96178ec328f#body_text
is schema:about of	named entity 'In December' named entity 'antigen' named entity 'diagnostic tests' named entity 'China' named entity 'diagnosis' named entity 'chain reaction' named entity 'published' named entity 'ranking' named entity 'Evaluation' named entity 'Tests' named entity 'Decision-Making' named entity 'For' named entity 'STUDY' named entity 'FIELD' named entity 'CAUSED BY' named entity 'COUNTRY' named entity 'USED' named entity 'PNEUMONIA' named entity 'ANTIGEN DETECTION' named entity 'SOLUTIONS' named entity 'CELL CULTURE' named entity 'POSSESSED' named entity 'PARAMETERS' named entity 'MUTUAL' named entity 'CHEST CT' named entity 'DETECTION' named entity 'CLINICAL PRACTICE' named entity 'ORGANIZATION' named entity 'RESOURCES' named entity '2019' named entity 'DIAGNOSTIC' named entity 'Computerized tomography' named entity 'coronavirus' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'COVID-19' named entity 'IgM' named entity 'cell culture' named entity 'SARS-CoV-2' named entity 'diagnostic tests' named entity 'diabetes mellitus' named entity 'chest X-ray' named entity 'PROMETHEE' named entity 'China' named entity 'PROMETHEE' named entity 'COVID-19' named entity 'This' named entity 'comparing' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'chest CT scan' named entity 'diagnostic tests' named entity 'SARS-CoV-2' named entity 'virus' named entity 'COVID-19' named entity 'COVID' named entity 'ideal solution' named entity 'complement' named entity 'diagnostic tests' named entity 'asymptomatic people' named entity 'chest CT' named entity 'rRT-PCR' named entity 'chest imaging' named entity 'diagnostic tests' named entity 'decision matrix' named entity 'oropharyngeal' named entity 'PROMETHEE' named entity 'TOPSIS' named entity 'nucleic acid' named entity 'combination' named entity 'MCDM' named entity 'SARS-CoV-2' named entity 'chest CT' named entity 'diagnostic methods' named entity 'COVID' named entity 'PROMETHEE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software